The government's decisions to ease regulatory norms for clearing foreign-made vaccines for use in India and an in-principle consensus on an indemnity waiver are intended to facilitate supply of Pfizer's vaccine against Covid-19, which officials hope can be made by July.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3gkEeo3
कोई टिप्पणी नहीं:
एक टिप्पणी भेजें